Assessment of Nerve Regeneration Across Nerve Allografts Treated with TacrolimusHAN HAISHENG; ZUO SONGJIE; LI XIN et al.Artificial cells, blood substitutes, and biotechnology. 2008, Vol 36, Num 5, pp 465-474, 10 p.Article

TUMEFACTIVE DEMYELINATION, AN UNCOMMON FORM OF TACROLIMUS NEUROTOXICITYKIM, S. H; KIM, W; LEE, K. W et al.Neurology. 2011, Vol 76, Num 7, pp 672-674, issn 0028-3878, 3 p.Article

Immunophilin FK506 loaded in chitosan guide promotes peripheral nerve regenerationXIAOXIA LI; WEI WANG; GUOQIANG WEI et al.Biotechnology letters. 2010, Vol 32, Num 9, pp 1333-1337, issn 0141-5492, 5 p.Article

Tacrolimus leukoencephalopathy: A neuropathologic confirmationLAUIGNE, Catherine M; SHRIER, David A; KETKAR, Manoj et al.Neurology. 2004, Vol 63, Num 6, pp 1132-1133, issn 0028-3878, 2 p.Article

Mechanisms of the sensory effects of tacrolimus on the skinPEREIRA, U; BOULAIS, N; LEBONVALLET, N et al.British journal of dermatology (1951). 2010, Vol 163, Num 1, pp 70-77, issn 0007-0963, 8 p.Article

Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipientsROY, Jean Nicholas; BARAMA, Azemi; POIRIER, Charles et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 9, pp 659-665, issn 1744-6872, 7 p.Article

Differential impact of the CYP3A5^*1 and CYP3A5^*3 alleles on pre-dose concentrations of two tacrolimus formulationsWEHLAND, Markus; BAUER, Steffen; BRAKEMEIER, Susanne et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 4, pp 179-184, issn 1744-6872, 6 p.Article

Isolation and Identification of a Novel Microorganism Producing the Immunosuppressant TacrolimusHYUNG SOO KIM; YOUNG IN PARK.Journal of bioscience and bioengineering. 2008, Vol 105, Num 4, pp 418-421, issn 1389-1723, 4 p.Article

Topical tacrolimus has a limited direct effect on ultraviolet B-irradiated keratinocytes: implications for its photocarcinogenic potentialLAN, C.-C. E; YU, H.-S; HUANG, S.-M et al.Clinical and experimental dermatology (Print). 2010, Vol 35, Num 2, pp 173-179, issn 0307-6938, 7 p.Article

Bioequivalence of a new strength tacrolimus capsule under developmentBEKERSKY, I; DRESSLER, D; BOSWELL, G. W et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1457-1459, issn 0041-1345Conference Paper

Renal histology with varying FK506 blood levelsGABER, L. W; MOORE, L. W; REED, L et al.Transplantation proceedings. 1997, Vol 29, Num 1-2, issn 0041-1345, p. 186Conference Paper

Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicityVENNETI, Sriram; MOSS, Heather E; LEVIN, Marc H et al.Journal of the neurological sciences. 2011, Vol 301, Num 1-2, pp 112-115, issn 0022-510X, 4 p.Article

Characterisation of a γ-butyrolactone receptor of Streptomyces tacrolimicus: effect on sporulation and tacrolimus biosynthesisSALEHI-NAJAFABADI, Zahra; BARREIRO, Carlos; MARTINEZ-CASTRO, Miriam et al.Applied microbiology and biotechnology. 2011, Vol 92, Num 5, pp 971-984, issn 0175-7598, 14 p.Article

CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantationGOTO, Maki; MASUDA, Satohiro; KIUCHI, Tetsuya et al.Pharmacogenetics (London). 2004, Vol 14, Num 7, pp 471-478, issn 0960-314X, 8 p.Article

Calcineurin-inhibitor induced pain syndrome (CIPS) : a severe disabling complication after organ transplantationGROTZ, Wolfgang H; BREITENFELDT, Marie K; BRAUNE, Stefan W et al.Transplant international. 2001, Vol 14, Num 1, pp 16-23, issn 0934-0874Article

Effects of tacrolimus on an organotypic raft-culture model mimicking oral mucosaRAUTAVA, J; PÖLLÄNEN, M; LAINE, M. A et al.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 8, pp 897-903, issn 0307-6938, 7 p.Article

Compatibility of Tacrolimus Ointment with Corticosteroid Ointments of Varying PotenciesPAPPAS, Lisa; KISS, Alex; LEVITT, Jacob et al.Journal of cutaneous medicine and surgery. 2009, Vol 13, Num 3, pp 140-145, issn 1203-4754, 6 p.Article

Effects of tacrolimus on hyperlipidemia after successful renal transplantationMCCUNE, T. R; THACKER, L. R; SELMAN, S. H et al.Transplantation. 1998, Vol 65, Num 1, pp 87-92, issn 0041-1337Conference Paper

Dermatologie = DermatologyHARMS, M; PILETTA, P.Médecine et hygiène. 1997, Vol 55, Num 2146, pp 60-69, issn 0025-6749, 9 p.Article

Long-term treatment of generalised myasthenia gravis with FK506 (tacrolimus)KONISHI, T; YOSHIYAMA, Y; TAKAMORI, M et al.Journal of neurology, neurosurgery and psychiatry. 2005, Vol 76, Num 3, pp 448-450, issn 0022-3050, 3 p.Article

An open study of tacrolimus therapy in Rasmussen encephalitisBIEN, C. G; GLEISSNER, U; SASSEN, R et al.Neurology. 2004, Vol 62, Num 11, pp 2106-2109, issn 0028-3878, 4 p.Article

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantationSTAATZ, Christine E; TETT, Susan E.Clinical pharmacokinetics. 2004, Vol 43, Num 10, pp 623-653, issn 0312-5963, 31 p.Article

Tacrolimus and transplantation: A decade in reviewFUNG, John J.Transplantation. 2004, Vol 77, Num 9, pp S41-S43, issn 0041-1337, SUPArticle

Monotherapy with tacrolimus and corticosteroid withdrawalLAUZURICA, R; ARA, J; FERNANDEZ, P et al.Transplantation proceedings. 2002, Vol 34, Num 1, pp 120-121, issn 0041-1345Conference Paper

Topical tacrolimus is effective for facial lesions of psoriasisYAMAMOTO, Toshiyuki; NISHIOKA, Kiyoshi.Acta dermato-venereologica. 2000, Vol 80, Num 6, issn 0001-5555, p. 451Article